Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG

Coronavirus disease 2019 (COVID-19) convalescent plasma has emerged as a promising therapy and has been granted Emergency Use Authorization by the US Food and Drug Administration for hospitalized COVID-19 patients. We recently reported results from interim analysis of a propensity score–matched stud...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Pathol
Asıl Yazarlar: Salazar, Eric, Christensen, Paul A., Graviss, Edward A., Nguyen, Duc T., Castillo, Brian, Chen, Jian, Lopez, Bevin V., Eagar, Todd N., Yi, Xin, Zhao, Picheng, Rogers, John, Shehabeldin, Ahmed, Joseph, David, Masud, Faisal, Leveque, Christopher, Olsen, Randall J., Bernard, David W., Gollihar, Jimmy, Musser, James M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Investigative Pathology. Published by Elsevier Inc. 2021
Konular:
Regular Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609241/
https://ncbi.nlm.nih.gov/pubmed/33157066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2020.10.008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller